Endotracheal Tube Market is Estimated to Witness High Growth Owing to Rising Incidence of Respiratory Diseases and Growth in the Number of ICU Beds
The endotracheal tube market is estimated to be valued at USD 1,040.7 Mn in 2024, exhibiting a CAGR of 7.4% over the forecast period (2024-2031). The rising prevalence of chronic respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), has increased the demand for artificial airway devices. Furthermore, the growing number of ICU beds in hospitals worldwide is also propelling the market growth.
Market Dynamics:
The endotracheal tube market growth is primarily driven by the rising incidence of respiratory diseases and growing geriatric population. Chronic obstructive pulmonary disease (COPD) and asthma are the most common respiratory diseases worldwide. As per the WHO estimates released in 2020, there were an estimated 455 million cases of COPD and 3.9 million deaths globally. The risk of COPD development increases with age. The growing elderly population prone to respiratory disorders will subsequently increase the demand for endotracheal tubes over the forecast period.
Moreover, the increasing number of ICU beds in hospitals especially in developing nations is another major factor responsible for market growth. ICU units equipped with mechanical ventilators require endotracheal tubes to deliver oxygen and anesthesia gases to the lungs.
Increasing Number of ICU Admissions Driving Demand for Endotracheal Tubes
One of the key drivers of the endotracheal tube market is the rising number of patients requiring intensive care. Endotracheal intubation is commonly performed on patients admitted to the ICU for various medical conditions that impair respiratory function such as respiratory diseases, cardiac illnesses, trauma injuries, and others. As the global elderly population grows and the prevalence of chronic diseases increases, ICU admission rates have seen consistent growth over the past decade. This has translated to greater demand for single-use endotracheal tubes that help facilitate mechanical ventilation in critically ill patients. With aging demographics and burden of comorbidities projected to continue rising worldwide, ICU visits and subsequently endotracheal tube usage is expected to keep climbing.
Technological Advancements Enabling Better Patient Ventilation Outcomes
Advancements in endotracheal tube design and functionality represent another key driver propelling market revenues. Manufacturers have enhanced tube materials, cuff designs, and incorporation of integrated technologies to optimize patient ventilation and reduce complications. Some examples include tubes made of silicone and polyurethane blends that are softer and reduce mucosal injury risk. New cuff designs, coatings, and pressure monitoring systems help achieve an effective seal without over-inflating the cuff and damaging the tracheal wall. Endotracheal tubes have also been integrated with technologies like in-line suctioning and secretion management systems that help clear secretions and reduce ventilator-associated pneumonia incidence. Such innovations enable better patient outcomes, reducing length of mechanical ventilation and hospital stays. This clinical value offered by technologically advanced tubes to healthcare facilities and providers is a primary driver complementing volume growth in the endotracheal tube market.
Pricing Pressure from Generic & Low-Cost Alternatives
One major restraint faced by endotracheal tube manufacturers worldwide is the pricing pressure exerted by the growing availability of low-cost generic and private label alternatives. Being commodity medical devices, endotracheal tubes are regularly procured in bulk by hospitals to stock ICUs and emergency departments. This makes them highly susceptible to race-to-the-bottom pricing competition from local and Asian generic importers offering lower prices. The dominance of few global players also enables large hospitals and group purchasing organizations to negotiate aggressive tenders and long-term supply contracts applying downward pressure on established brand prices. While technological innovations may account for some premium, overall average selling prices have declined over the past 5 years for players in major endotracheal tube markets like the U.S. Fighting price erosion while maintaining margins remains a key challenge that manufacturers must overcome to sustain profitable growth.
Supply Chain Disruptions during COVID-19 Pandemic
The COVID-19 pandemic posed significant restraints on the endotracheal tube market globally through 2020-2021. Massive surge in critically ill patients requiring ventilation support at the peak of the outbreak strained existing ICU capacities and tube inventory levels. Moreover, widespread lockdowns and restrictions disrupted international supply chains, leading to temporary shortages. This was exacerbated by export restrictions imposed by certain governments trying to prioritize domestic requirements. Challenges in raw material procurement, manufacturing, and logistics delays constrained tube production scales just when global demand skyrocketed. While market conditions have normalized since, the risk of future pandemics and supply chain disruptions remains a key macro-level restraint on sustained growth that manufacturers must strategize to mitigate.
Growth in Demand from Developing Nations
One major opportunity for endotracheal tube vendors lies in geographic expansion to emerging markets in Asia Pacific, Latin America, Middle East, and Africa. These regions are experiencing rapid economic development and rising healthcare investments, translating to greater demand for critical care infrastructure and equipment. Countries like India, China, Brazil, and Indonesia are seeing ICU bed numbers rise annually in line with growing middle-class populations and focus on non-communicable diseases. With increased medical tourism as well, demand for high-quality, U.S. Food and Drug Administration approved tubes is on the rise from hospitals in developing markets previously relying on inferior substitutes. By customizing product attributes, marketing strategies and pricing for these high-growth regions, global companies can tap significant untapped potential over the coming decade.
Link - https://www.coherentmarketinsights.com/market-insight/endotracheal-tube-market-2564
Key Developments
- In August 2021, Researchers at the Children's Hospital of Philadelphia (CHOP), announced that they had developed novel coating for endotracheal tubes that releases antimicrobial peptides to combat bacterial infections. This innovation aims to reduce upper-airway inflammation during intubation, potentially preventing chronic conditions like subglottic stenosis.
- In May 2021, Medtronic, medical technology company, announced the U.S. commercial launch of the SonarMed airway monitoring system. The SonarMed airway monitoring system utilizes acoustic technology to check for endotracheal tube (ETT) obstruction and verify position in real-time, giving clinicians vital information required to make more informed, life-saving decisions for their patients
- In November 2020, GE Healthcare, a healthcare company, announced that they had announced a new artificial intelligence (AI) algorithm to help clinicians assess Endotracheal Tube (ETT) placements
Key Players
Sterimed Group, ICU Medical, Inc., Advin Health Care, Medtronic, Van Oostveen Medical B.V., Teleflex Incorporated, Convatec Inc., Fuji Systems Corp, Hollister Incorporated, Well Lead Medical Co.,Ltd, Medline, Angiplast Pvt Ltd, SEWOON MEDICAL Co., Ltd., and Kimberly-Clark
